Ads
related to: eli lilly- Our Top 4 Picks for AI
Ignore AI at your own risk
How we find our real winners
- Motley Fool Stock Advisor
Get Two New Stock Recommendations
Straight To Your Inbox Each Month.
- Our #1 AI Tech Stock Pick
Should You Invest in AI Now?
AI Tech Investment Alert
- Double Down Buy Alert
Where to Invest $1,000
Top Stocks for 2024
- Our Top 4 Picks for AI
Search results
Britain Poised to Offer Eli Lilly’s Weight-Loss Drug to Patients
Bloomberg· 10 hours agoEli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity...
Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In Spotlight
Investor's Business Daily· 2 hours agoTop drugmakers Eli Lilly and Novo Nordisk also make this list of top growth stocks. Eli Lilly now...
Barclays bullish on Eli Lilly stock with positive outlook By Investing.com
Investing.com· 1 day agoOn Monday, Barclays expressed a positive stance on Eli Lilly (NYSE:LLY) stock, maintaining an...
Eli Lilly and Company (NYSE:LLY) Major Shareholder Lilly Endowment Inc Sells 22,206 Shares of Stock
ETF DAILY NEWS· 17 hours agoEli Lilly and Company (NYSE:LLY – Get Free Report) major shareholder Lilly Endowment Inc sold 22,206 shares of the business’s stock in ...
Eli Lilly Beefs Up Neuro Pipeline With Addition Of Preclinical ALS, Dementia Prospect
Benzinga via Yahoo Finance· 1 day agoOn Monday, privately held QurAlis Corporation entered into an exclusive license agreement with Eli ...
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 5 days agoEli Lilly stock rocketed and broke out earlier this month after unveiling promising results for its...
Eli Lilly executive sells over $600k in company stock By Investing.com
Investing.com· 1 day agoEli Lilly & Co (NYSE:LLY) executive Donald A. Zakrowski, who serves as the Senior Vice President of...
Britain considers offering Lilly weight-loss drug on better terms than Wegovy
Reuters via AOL· 4 hours agoBritain's medical costs regulator on Tuesday recommended Eli Lilly's weight-loss drug Mounjaro for...
Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030,...
INSIDER via Yahoo News· 3 days agoZepbound is Eli Lilly's new weight-loss drug.Brendan McDermid/Reuters The anti-obesity drug market...
Lilly Endowment sells over $18 million in Eli Lilly stock By Investing.com
Investing.com· 1 day agoLilly Endowment Inc., a major shareholder in Eli Lilly & Co (NYSE:LLY), has recently sold a significant portion of its holdings in the ...